PharmaShots | Incisive News in 3 Shots

Subscribe Now

HD201

Prestige BioPharma Reports EMA's Acceptance of Marketing Authorization Application for its Tuznue (trastuzumab- biosimilar)

Prestige BioPharma Reports EMA's Acceptance of Marketing Authorization Application for its Tuznue (trastuzumab- biosimilar)

May 29, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us